8CC Institutional Ownership, Buyers - Cocrystal Pharma, Inc.

Institutional and Fund Ownership - Buyers

Major holders that have opened new positions in Cocrystal Pharma, Inc. include Raymond James Financial Inc .

This page shows changes in the ownership structure by listing institutions, funds, and major shareholders that have increased their holdings or opened new positions in the last reporting period. Green rows indicate new positions. Click the link icon to see the full transaction history.

Upgradeto unlock premium data.

File Date	Source	Investor	Shares	Δ Shares (%)	Reported Value ($1000)	Δ Value (%)
2025-08-15	13F	Tower Research Capital LLC (TRC)	3,663	87.17	5	150.00
2025-07-24	NP	FSMAX - Fidelity Extended Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	39,403	6.46	68	4.69
2025-08-14	13F	Raymond James Financial Inc	215		0
2025-08-14	13F	Susquehanna International Group, Llp	40,619	20.59	61	27.66
2025-08-14	13F	Wells Fargo & Company/mn	1,812	30,100.00	3
2025-08-14	13F	Bank Of America Corp /de/	9,101	0.88	14	8.33
2025-07-24	NP	FCFMX - Fidelity Series Total Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value	9,629	11.10	17	14.29
2025-08-14	13F	UBS Group AG	21,915	30.40	33	39.13
2025-08-12	13F	Proequities, Inc.	0		0

DE:8CC / Cocrystal Pharma, Inc. - Institutional Ownership - Buyers

Institutional and Fund Ownership - Buyers

Other Listings